Clinical Trial Update: Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intramuscular SP306 to subcutaneous DT in Japanese adolescents aged 11-12 evaluating vaccines for tetanus, diphtheria, and pertussis; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• DT (Diphtheria-Tetanus vaccine)
• SP306

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Tetanus, Diphtheria | Phase 3 | Status: COMPLETED | Results posted: 2015-10-08